期刊文献+

Comparative effectiveness of first-line therapies for eradication of antibiotic-resistant Helicobacter pylori strains:A network metaanalysis

下载PDF
导出
摘要 BACKGROUND As a first-line treatment regimen for Helicobacter pylori(H.pylori)infection,antibiotic therapy is widely used worldwide.However,the question of increasing antibiotic resistance must be considered.Given this issue,we need to find ways to reduce drug resistance.This study examined all currently available first-line regimens and compared them with standard triple treatment through a network meta-analysis of randomized controlled trials(RCTs).AIM To compare first-line treatment regimens for eradication of antibiotic-resistant H.pylori strains.METHODS To compare the effectiveness of the first-line regimens for treating H.pylori infection,a Bayesian network meta-analysis was applied to process data extracted from RCTs.The plausible ranking for each regimen was assessed by the surface under the cumulative ranking curve(SUCRA).In addition,we conducted a relevant search by reference citation analysis.RESULTS Twenty-five RCTs involving 12029 participants[including 1602 infected with clarithromycin(CAM)-resistant strains and 1716 infected with metronidazole(MNZ)-resistant strains]were included,in which a total of seven regimens were used for H.pylori eradication.The results showed that dual therapy containing a high-dose proton pump inhibitor(HDDT)[odds ratio(OR):4.20,95%confidence interval(CI):2.29-8.13]was superior to other therapies for all patients,including those with CAM/MNZ-resistant H.pylori infection.In the comparative effectiveness ranking,for CAM-resistant H.pylori,HDDT(OR:96.80,95%CI:22.46-521.9)had the best results,whereas standard triple therapy ranked last(SUCRA:98.7%vs 0.3%).In the subgroup of high cure rates(≥90%),HDDT was also generally better than other therapies.CONCLUSION For the eradication of CAM-and MNZ-resistant H.pylori strains,HDDT exhibited considerable advantages.The studies of CAM-resistant H.pylori were based on small samples due to a lack of antibiotic sensitivity tests in many RCTs,but the results showed that all patients,including those with CAM-resistant H.pylori infection,had a concordant trend.Overall,HDDT may be a reference for RCTs and other studies of H.pylori eradication.
机构地区 Department of Pharmacy
出处 《World Journal of Clinical Cases》 SCIE 2022年第35期12959-12970,共12页 世界临床病例杂志
  • 相关文献

参考文献1

二级参考文献14

  • 1N.Broutet,S.Tchamgoué,E.Pereira,H.Lamouliatte,R.Salamon,F.Mégraud.Risk factors for failure of Helicobacter pylori therapy — results of an individual data analysis of 2751 patients[J]. Alimentary Pharmacology & Therapeutics . 2002 (1)
  • 2Jyh-Ming Liou,Chieh-Chang Chen,Mei-Jyh Chen,Chien-Chuan Chen,Chi-Yang Chang,Yu-Jen Fang,Ji–Yuh Lee,Shih-Jer Hsu,Jiing-Chyuan Luo,Wen-Hsiung Chang,Yao-Chun Hsu,Cheng-Hao Tseng,Ping-Huei Tseng,Hsiu-Po Wang,Ueng-Cheng Yang,Chia-Tung Shun,Jaw-Town Lin,Yi-Chia Lee,Ming-Shiang Wu.Sequential versus triple therapy for the first-line treatment of Helicobacter pylori : a multicentre, open-label, randomised trial[J].The Lancet.2012
  • 3Malfertheiner P,Megraud F,O’Morain C,Bazzoli F,El-Omar E,Graham D,Hunt R,Rokkas T,Vakil N,Kuipers E J.Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report[].Gut.2006
  • 4Hossein Sardarian,Hafez Fakheri,Vahid Hosseini,Tarang Taghvaei,Iradj Maleki,Marjan Mokhtare.Comparison of Hybrid and Sequential Therapies for H elicobacter pylori Eradication in I ran: A Prospective Randomized Trial[J].Helicobacter.2012(2)
  • 5Marshall BJ.Helicobacter pylori. The American journal of Gastroenterology . 1994
  • 6Graham David Y,Fischbach Lori.Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut . 2010
  • 7Hsu Ping-I,Wu Deng-Chyang,Wu Jeng-Yih,Graham David Y.Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 days. Helicobacter . 2011
  • 8Naomi Uemura,Shiro Okamoto.Effect of Helicobacter Pylori Eradication on Subsequent Development of Cancer after Endoscopic Resection of Early Gastric Cancer in Japan[J]. Gastroenterology Clinics of North America . 2000 (4)
  • 9Vaira D,Miglioli M,Mulè P,Holton J,Menegatti M,Vergura M,Biasco G,Conte R,Logan R P,Barbara L.Prevalence of peptic ulcer in Helicobacter pylori positive blood donors. Gut . 1994
  • 10Rauws EA,Tytgat GN.Cure of duodenal ulcer associated with eradication of Helicobacter pylori. The Lancet . 1990

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部